4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide

C55H63N9O9S — CID 175757109

IUPAC4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide
SMILESCC(C)(C#N)c1ccccc1[C@@H]1CCCN1C1CC2(CCN(c3ccc(C(=O)NS(=O)(=O)c4cc5c(c([N+](=O)[O-])c4)N[C@H](C4CCC(O)CC4)CO5)c(N4c5cc6cc[nH]c6nc5O[C@H]5CCOC[C@@H]54)c3)CC2)C1
InChIInChI=1S/C55H63N9O9S/c1-54(2,32-56)41-7-4-3-6-39(41)43-8-5-20-62(43)36-28-55(29-36)17-21-61(22-18-55)35-11-14-40(44(25-35)63-46-24-34-15-19-57-51(34)59-53(46)73-48-16-23-71-31-47(48)63)52(66)60-74(69,70)38-26-45(64(67)68)50-49(27-38)72-30-42(58-50)33-9-12-37(65)13-10-33/h3-4,6-7,11,14-15,19,24-27,33,36-37,42-43,47-48,58,65H,5,8-10,12-13,16-18,20-23,28-31H2,1-2H3,(H,57,59)(H,60,66)/t33?,37?,42-,43-,47-,48-/m0/s1
InChIKeyQHJWWKJYDASUJI-FJIYEVALSA-N
MW1026.23 g/mol
LogP8.39
Rot. Bonds10

About 4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide

4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide (PubChem CID 175757109) has the molecular formula C55H63N9O9S and a molecular weight of 1026.23 g/mol. Its IUPAC name is 4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide.

Molecular Properties

Compound Name4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide
PubChem CID175757109
Molecular FormulaC55H63N9O9S
Molecular Weight1026.23 g/mol
Exact Mass1025.45
IUPAC Name4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide
SMILESCC(C)(C#N)c1ccccc1[C@@H]1CCCN1C1CC2(CCN(c3ccc(C(=O)NS(=O)(=O)c4cc5c(c([N+](=O)[O-])c4)N[C@H](C4CCC(O)CC4)CO5)c(N4c5cc6cc[nH]c6nc5O[C@H]5CCOC[C@@H]54)c3)CC2)C1
InChIInChI=1S/C55H63N9O9S/c1-54(2,32-56)41-7-4-3-6-39(41)43-8-5-20-62(43)36-28-55(29-36)17-21-61(22-18-55)35-11-14-40(44(25-35)63-46-24-34-15-19-57-51(34)59-53(46)73-48-16-23-71-31-47(48)63)52(66)60-74(69,70)38-26-45(64(67)68)50-49(27-38)72-30-42(58-50)33-9-12-37(65)13-10-33/h3-4,6-7,11,14-15,19,24-27,33,36-37,42-43,47-48,58,65H,5,8-10,12-13,16-18,20-23,28-31H2,1-2H3,(H,57,59)(H,60,66)/t33?,37?,42-,43-,47-,48-/m0/s1
InChIKeyQHJWWKJYDASUJI-FJIYEVALSA-N
XLogP8.39
TPSA228.52 Ų
H-Bond Donors4
H-Bond Acceptors15
Rotatable Bonds10
Heavy Atoms74
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001026.23
LogP ≤ 58.39
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide?
The IUPAC name of 4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide (CID 175757109) is 4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide.
What is the SMILES notation for 4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide?
The canonical SMILES for 4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide is CC(C)(C#N)c1ccccc1[C@@H]1CCCN1C1CC2(CCN(c3ccc(C(=O)NS(=O)(=O)c4cc5c(c([N+](=O)[O-])c4)N[C@H](C4CCC(O)CC4)CO5)c(N4c5cc6cc[nH]c6nc5O[C@H]5CCOC[C@@H]54)c3)CC2)C1.
What is the InChIKey of 4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide?
The InChIKey is QHJWWKJYDASUJI-FJIYEVALSA-N. The full InChI is InChI=1S/C55H63N9O9S/c1-54(2,32-56)41-7-4-3-6-39(41)43-8-5-20-62(43)36-28-55(29-36)17-21-61(22-18-55)35-11-14-40(44(25-35)63-46-24-34-15-19-57-51(34)59-53(46)73-48-16-23-71-31-47(48)63)52(66)60-74(69,70)38-26-45(64(67)68)50-49(27-38)72-30-42(58-50)33-9-12-37(65)13-10-33/h3-4,6-7,11,14-15,19,24-27,33,36-37,42-43,47-48,58,65H,5,8-10,12-13,16-18,20-23,28-31H2,1-2H3,(H,57,59)(H,60,66)/t33?,37?,42-,43-,47-,48-/m0/s1.
What are the key properties of 4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide?
4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide has a molecular weight of 1026.23 g/mol, XLogP of 8.39, 10 rotatable bonds, 4 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[2-[(2S)-2-[2-(2-cyanopropan-2-yl)phenyl]pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-[(3S,8S)-5,9-dioxa-2,11,13-triazatetracyclo[8.7.0.03,8.012,16]heptadeca-1(10),11,14,16-tetraen-2-yl]-N-[[(3R)-3-(4-hydroxycyclohexyl)-5-nitro-3,4-dihydro-2H-1,4-benzoxazin-7-yl]sulfonyl]benzamide is sourced from PubChem (CID 175757109), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).